lignin-derived polyphenolic composition with ammonium molybdate BP-C2

{
  "id": "MLC-T-ONC-014782",
  "term": "lignin-derived polyphenolic composition with ammonium molybdate BP-C2",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable solution containing lignin-derived benzene-polycarboxylic acids mixed with ammonium molybdate, with potential use as an adjuvant and with potential radioprotective and regenerative activities. Upon oral administration, lignin-derived polyphenolic composition with ammonium molybdate BP-C2 is also able to stimulate the innate immune system and upregulates a variety of cytokines including interferon (IFN), tumor necrosis factor-alpha (TNF-alpha), granulocyte macrophage-colony stimulating factor (GM-CSF), and various interleukins (ILs) such as IL-6, IL-22 and IL-25, and induces the production of innate lymphoid cells. BP-C2 stimulates the production of intestinal epithelial cells thereby protecting the gastrointestinal (GI) tract against GI-induced cytotoxic side effects caused by certain anti-tumor agents. Additionally, BP-C2 scavenges free radicals, inhibits lipid oxidation, and protects cells against radiation-induced damage. Molybdenum, an essential micronutrient, acts as a cofactor in multiple detoxification system enzymes. BP-C2 may also stimulate the production of hematopoietic progenitor cells, thereby correcting hematological abnormalities such as anemia, thrombocytopenia and neutropenia, which are also caused by certain anti-cancer agents.",
  "synonyms": [
    "benzene-poly-carboxylic acid complex with molybdenum BP-C2",
    "molybdenum salts of benzene-polycarboxylic acids BP-C2"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/lignin-derived-polyphenolic-composition-with-ammonium-molybdate-bp-c2/"
}